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We conclude that mortality within 24 hrs following PTCA in patients not
having emergency CABG is more than 3 times higher in women than men
despite comparable age, extent of coronary disease, and procedural reduc-
tion of luminal stenosis. Although the cause of the increased mortality in
women is unclear, non-cardiac complications in women may be a contribut-
ing factor.
Cost Savings with 6 Compared to 8 French
Guiding Catheters Used in Coronary
Angioplasty
Delayed Views Post PTCA Predict Acute and
In-Hospital Complications in Patients with
Unstable Angina
No T or MD at Tor MOat NoTorMDat
15 min (N ~ 170) 15 min. (N ~ 501 1 min. IN ~ 202)
Acute closure (%) 0*'; 8' 2 '
Emergent bypass (%) at 4t 0.5
Any ischemic in-
hospital event (%) 3.5' 10' 4
John A. Ambrose, Samin K. Sharma, Orlandino D. Almeida, Jonathan D. Marmur,
Sabino Torre, Douglas Israel. Ram Bongu, TAUSA trial. Mount Sinai Hospital, New
York, NY
Adverse in-hospital ischemic complications are increased following PTCA in
unstable angina in comparison to stable angina and may relate to the high in-
cidence of intracoronarythrombus associated with unstable angina. We have
previously noted that following PTCA, delayed views (15 min. postPTCA)
often demonstrate lesional irregularities and filling defects suggestive of
thrombus not noted immediately (1 min.) following PTCA. In the TAUSA trial,
unstable angina patients were randomized to Urokinase or placebo during
PTCA of the culprit lesion. One and 15 minute post PTCA angiograms were
routinely assessed for major dissection (MDl or thrombus (T) formation. Be-
cause ischemic events were increased with urokinase, only placebo patients
were evaluated in this analysis. MD was defined as a spiral D or a D causing
>50% diameter reduction.
Variables asso-
ciated with increased total cost included: hypercholesteremia, 8F GC, and
prolonged cath lab time. Less contrast was used with 6F; visualization was
improved with 8F Gc.
Thus; The use of 6F GC resulted in dramatic cost savings during elective
PTCA. primarily due to a reduction in post procedure hospital costs. Visual-
ization was improved with 8F GC; however, there was no difference in proce-
dural or clinical outcomes. The decision to use 6F GC is a dynamic balance
between angiographic quality and cost reduction.
Cath Lab $ Post-PTCA $ Total $
Supplies RN MD Hospital MD
6F 1470 106 1156 1026 181 3956
8F 1724 118 1207 1705 297 5073
P 0003 NS NS 004 008 003
'p < 0.005, t p ~ 0.05, 'p < 010
The presence of T or MD at 15 min. post PTCA was associated with a
higher incidence of acute closure and other adverse clinical events vs. no T
or MD at 15 min. post PTCA. There was a trend to a lower incidence of acute
closure when the 15 min. angiogram revealed no T or MD in comparison to
no T or MD at 1 min. post PTCA. Thus, T or MD on delayed views identify a
group of patients who are at a higher risk of adverse events. The absence of
Tor MD at 15 min. following PTCA in unstable angina is associated with few
adverse events. These data suggest that delayed views should be routinely
performed following PTCA in unstable angina.
J. DaVid Talley, Patrick D. Mauldin, Edmund R. Becker, Massoud A. Lessar.
University of Louisville, Louisville, KY; Emory University, Atlanta, GA
To determine the possibility of cost savings with smaller (6 French, F) vs
larger (8 F) guiding catheters (GC) during PTCA, a prospective random-
ized trial was performed in 160 patients at 3 separate hospitals. Standard
PTCA balloon catheters were used. Resource utilization was calculated with
"bottom-up" cost analysis and physician cost was determined with use of
the resource based relative value scale. Endpoints included: cost of PTCA
supplies, support personal, post-PTCA room, physician; quantitative angiog-
raphy; and clinical success. (Mean cost were: R2 = 0.25)
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Mortality within 24 Hours of Coronary
Intervention is Greater in Women than Men
Women Men P
Number of Patients (%) 21/1345 (1.6%) 11/2282 (0.5%) 0.001
Age (years ± SO) 66.0 ± 14.6 667 ± 10.4 NS
PriorMI(%) 9/21 (43%) 6/11 (54%) NS
Prior CABG (%) 2/21 (10%) 2/11 (18%) NS
Emergent PTCA (%) 12/21 (57%) 8/11 (73%1 NS
Cardiogenic Shock (%) 11/21 (52%) 6/11 (54%I NS
Acute MI(%I 12/21 (57%) 8/11 (72'10) NS
Thrombolytics (%) 8/21 (38%) 5/11(45%) NS
Triple Vessel CAD (%) 10/21 (48%) 7/11(63%) NS
Post-PTCA Stenosis <50% (%) 16/21 (76%) 7/11 (63%) NS
Death in Cath Lab (%) 10/21(48%) 7/11 (63%) NS
Bleeding Complication (%) 4/21(19%) 0/11 (0%) 0.12
Cardiac Death (%1 17/21(81%) 11/11 (100%1 0.12
Length of Hospital Stay After Percutaneous
Transluminal Coronary Angioplasty: Clinical and
Angiographic Predictors
John A. Bittl. Mark W Wolfe, Gary S. Roubin, Marc Schweiger, Jeffrey M. Isner.
James J. Ferguson, Adam D. Cannon, Michael Cleman, Henry Cabin.
Ferdinand Leya, Raoul Bonan, John Strony, Burt Adelman, Heparin Registry
Investigators. Brigham & Women's Hospital, Boston, MA
Jon R. Resar, Jyostana N. Dalal, Vicki J. Coombs, Jeffrey A. Brinker. Johns Hopkins
Medicallnstitub'ons, Balb'more, MD
We have previously shown that gender does not influence the outcome
of emergency bypass surgery for complicated PTCA. To compare mortal-
ity within 24 hours of PTCA for men and women not going to emergency
CABG, we reviewed all patients (n = 3627) undergoing PTCA from 7/89 -
3/93 at our institution, and identified 32 (0.9%) who died within 24 hours of
coronary intervention.
Although several studies have shown that the complications of percuta-
neous transluminal coronary angioplasty (PTCA) are related to baseline clin-
ical and angiographic variables, it is uncertain whether the utilization of hos-
pital resources after PTCA also depends on the same characteristics. The
purpose of this study was to identify the factors responsible f·or prolonged
hospital stay ILOS) after PTCA. In 591 consecutive patients undergoing PTCA
at nine centers in North America, major or minor complications occurred in
91 patients (15.4%1 and were found to be related to the presence of multi-
vessel disease (p = 0.02). unstable angina Ip = 0.02). and advanced age (p
= 0.0021 on multivariable logistic regression analysis. As compared with a
median length of stay of 2.0 days (2.0, 4.0 [25th, 75th percentiles]) for 500
patients (84.6%) after uncomplicated PTCA, the length of stay was 9.0 days
(8.0, 18.01 for 19 patients (3.2%) requiring emergency bypass surgery (P <
0.001), and 6.0 days (3.0,10.5) for 65 patients 111.0%) with established or
threatened abrupt closure (P < 0.0011. On stepwise multilinear regression
analysis, however, no significant relation was found between LOS and base-
line variables; instead, LOS was increased only by PTCA complications:
Variable
Emergency CABG
Death
Myocardial infarction
Abrupt closure
Age
Female sex
Unstable angina
Multivessel disease
Complex lesion
11017-731
11017-741
11017-1091In conclusion, efforts directed at reducing resource utilization after PTCAshould focus on the development of new techniques to lower PTCA com-
plications rather than limit the access of patients with advanced age and
complex lesions to PTCA.
Revascularisation and Quality of Life: Improved
Self-Perceived Well-Being, FollOWing PTCA or
CABG Surgery
Martyn Farrer, Peter G. Reid, Catherine J. Albers, Julie Goodfellow, Douglas
S. Reid, Stephen S. Furniss, Philip C. Adams. Freeman Hospital. Newcastle upon
Tyne. and CASPE Outcomes Study. UK
Patients with chronic stable angina treated with either CABG In = 353 from
Oct 1988 to Dec 1989) or PTCA (n = 118 from Feb 1989 to Oct 1990) were
studied prospectively for 1 year after each procedure. Patients were similar
age 154 yrs ± 9 for PTCA vs 58 yrs ± 8 for CABG) but a higher proportion
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of patients treated by CABG were men (86% for CABG v 80% PTCA, P <
0.001) CABG patients were more likely to have had MI (60% vs PTCA 34%,
P < 0.001), intermittent claudication (16% vs PTCA 6%, P < 0.001). heart
failure (6% vs PTCA 2%), diabetes mellitus (6% vs PTCA 2%) but similar pro-
portion of strokes, smokers, and treated hypertension or hyperlipidaemia.
Pre-procedure both patient groups had similar proportions with; angina (98%
CABG v 93% PTCA). severe angina (grade 3 or4 Candian Cardiovascular Soci-
ety Class, 71 % CABG vs 64% PTCA), and number of antianginal drugs used.
We used the Nottingham Health Profile (NHP) to examine self-perceived well-
being and found pre-procedure scores to be very similar for both groups. De-
spite these similarities CABG patients had higher Brandt scores for severity
of coronary artery disease (p < 0.001) and a higher proportion with impaired
ventricles (p < 0.001).
Conventional 1 year clinical outcomes were: Deaths (all cause 7% CABG
vs 2.5% PTCA, ns), readmissions (31 % CABG vs 38% PTCA), angina (CABG
26% vs PTCA 61 %, P < 0.001), grade 3 + 4 angina (CABG 11 % vs PTCA
53%). Other measures of outcome were; self-perceived effort tolerance> 1
mile (CABG 68% vs PTCA 42%, P < 0.001). antianginal drug use (22% of
CABG patients vs 75% of PTCA, p < 0.001), 1 year self-perceived well-being
scores were greatly improved (p < 0.001 for all dimensions CABG, p < 0.001
for all dimensions PTCA except sleep p < 0.05, and social isolation, p < 0.02).
Scores at 1 year were worse in PTCA than CABG.
Conclusion: Whether cardiac revascularisation is by PTCA or CABG similar
clinical outcome measures including self-perceived well-being are applica-
ble. These may allow the development of outcome targets based not onlyon
conventional morbidity but also on improved patient-perceived well-being.
improvement in matched pts with comparable lesion location, vessel size
(RD). lesion severity IMLD) and acute gain. Multivariate analyses were per-
formed to determine the correlates of minimal lumen at follow-up and lu-
men loss. Matching was considered adequate since lesion distribution, RD
(3.09 vs 3.09 mm) and MLD (1.12 vs 1.12 mm) were equal in both groups.
Stenting lesulted in a larger increase in MLD than DCA (1.41 vs 1.20 mm;
p = 0.0002), similar late loss (0.57 vs 0.66 mm; p = NS) with subsequently
a larger MLD at follow-up (1.96 vs 1.66 mm; p = 0.0001). However, when
additional matching (n = 150 pts) for acute gain (1.34 vs 1.33 mm) was per-
formed,late lumen loss was significantly smaller after stenting 10.52 vs 0.75
mm; p = 0.007) leading to a favorable long-term MLD (1.90 vs 1.66 mm; p =
0.004) when compared with DCA. Multivariate analysis revealed device type,
vessel size and lumen gain as independent predictors for MLD at follow-up.
The changes in MLD are shown in cumulative distribution curves:
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-024*
0.12
0004
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'p value for comparison of CAVEAT-I sites pre vs. post CAVEAT
Device CAVEAT·I sites CAVEAT-II sites
pre-CAVEAT post-CAVEAT post-CAVEAT
n % % %
PTCA 539 838 443 685 307 78.1
DCA 69 10.7 91 14.1 39 9.9
Other 35 54 113 175 47 12
• P < 0.0001
There has been a significant decline in the proportion of procedures relying
exclusively on balloon angioplasty and paradoxically, despite the negative
findings of CAVEAT-I. a noteworthy trend towards an increase in use of DCA
and other devices at CAVEAT sites. This paradoxic increase in trend was still
evident when subgroup analysis of American and European CAVEAT-I sites
was performed. These findings suggest that even among investigators in the
trial, there is a lack of influence of CAVEAT-I data on clinical practice patterns.
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Comparative Results of Extraction Atherectomy
(TEC) in Vein Graft Lesions with and without
Thrombus
Mark Dooris, William W. O'Neill, Melissa May, Sue Glazier, Anne Lichtenberg,
Venu Reddy, Cindy L. Grines, Gregory S. Pavlides, Theodore L. Schreiber, Robert
D. Safian. William Beaumont Hospital, Royal Oak, MI
DCA = 1. STENT = a
We compared the results of extraction atherectomy ITEC) in 183 consecutive
vein grafts (SVG) with In = 59,32%) and without thrombus (n = 124,68%)
including clinical data, lesion morphology, immediate angiographic results
and in-hospital complications:
In conclusion, the long-term angiographic outcome of stenting seems
more favorable than of directional atherectomy due to a larger acute lumi-
nal gain and a substantial reduction in late luminal loss. It appears that the
late outcome after an intervention is not only related to extent of luminal
improvement but also to the mechanism of acute gain (device type).
Angina class IV (%)
Acute Ml at presentation*
Ejection fraction (%)
SVG age (years)
Total occlusion (%)*
Diffuse disease·
% Diameter stenosis pre
% Diameter stenosis post TEe·
% Diameter stenosis final"
Final diameter stenosis <50%·
Procedural success (%)*
No-reflow'
Death, CABG, MI"
11018-48 1
Influence of Randomized Trials on Clinical
Practice: A Comparison of Directional
Atherectomy and New Device Use Before and
After the CAVEAT Trial at CAVEAT Sites
Nowa Omoigui, Mitchell J. Silver, Lisa Rybicki, Monique Rosenthal, Robert
M. Califf, Eric J. Topol, CAVEAT Investigators. Cleveland Clinic Foundation,
Cleveland, Ohio, Duke University. Durham, North Carolina
In order to evaluate the impact of the Coronary Angioplasty versus Excisional
Atherectomy Trial (CAVEAT-I) on practice patterns of coronary intervention, a
week-long registry of the "universe" of all coronary interventions performed
at 35 investigational sites between April 18 and 22, 1994 was compared with
a similar registry obtained before the trial was initiated. A total of 97% of sites
responded. Additional sites which took part in CAVEAT·II comparing DCA and
PTCA in vein grafts were also audited for generalizability:
11018-461
11018-471 A Matched Comparison of the Longterm
Outcome of Directional Coronary Atherectomy
versus Coronary Stenting
Victor Umans, Rein Melkert, Peter de Jaegere, Pim de Feyter, Patrick Serruys.
Thoraxcenter Rotterdam, the Netherlands
Conclusions: For TEC of SVG, the presence of thrombus is associated with
more baseline lesion complexity, reduced clinical success, and increased risk
of no-reflow and clinical complications.
To compare the renarrowing process after atherectomy (DCA) and stenting,
we reviewed the cineangiograms from a prospectively collected series of
234 matched DCA and stent patients (pts) with identical baseline clinical and
angiographic characteristics. In addition, we explored whether the process
of luminal renarrowing was related to the extent or mechanism of luminal
